Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

New COVID-19 vaccines hit pharmacy shelves

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

AAP

Competition cop Lina Khan’s antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Fortune

How to Buy PFE For a 7% Discount, or Achieve a 16% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise

Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn’t spoken out

The Guardian - UK

Stocks Mixed Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. Stocks this morning are mixed, with the Dow Jones...

Barchart

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK

Pfizer Halts Development Of Twice-Daily Weight-Loss Drug; PFE Stock Slides

Pfizer said Friday it would not advance development of a twice-daily oral weight-loss drug because of its side effects.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Texas lawsuit claims Pfizer exaggerated effectiveness of Covid vaccine

State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death

The Guardian - US

Stock Market Reverses Higher After Powell Remarks; This Economic Index Weakest Since Dot-Com Bubble

The Innovator IBD 50 ETF outperformed with a 0.6% gain and could make its first close above the 200-day moving average since Sept. 12.

Investors Business Daily

Texas attorney general sues Pfizer, claiming vaccines didn’t end pandemic quickly enough

Experts argue other assertions made in the lawsuit filing are completely unsubstantiated, such as one claiming that vaccinated people were more likely to die from COVID-19, which Texas health data disputes.

The Texas Tribune

1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

Barchart

7 Companies Will Propel Profit More Than 100% Next Year: Analysts

It's only November — but if you're like most investors — 2024 is what matters now. And some S&P 500 companies already look primed to put up big numbers.

Investors Business Daily

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Medical Daily

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

USA Today Sports Media Group

Travis Kelce took a playful swipe at Aaron Rodgers in his interview with The Wall Street Journal

Rodgers isn't coming back from that one.

The Hindu

Exploring side effects

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…

Barchart

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning

Biogen and Eisai scored key victories in the quest for an Alzheimer's cure. But the race is just getting started.

Investors Business Daily

Stock Market Indexes Venture Into Positive Ground; Boeing Soars On Deal News

Stock market indexes took a tumble Monday after Moody's Investor's Service cut its rating on U.S. debt. Boeing surged on deal news.

StockNews.com

Can Pfizer (PFE) and AbbVie (ABBV) Cure Your Portfolio's Ailments?

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.

The Independent UK

Syphilis cases in US newborns skyrocketed in 2022. Health officials suggest more testing

Syphilis cases in U.S. newborns again are on the rise

Investors Business Daily

Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat

Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.

Investors Business Daily

Pfizer Stock Recovers, But Covid Products Drive 41% Sales Decline, Losses

Pfizer stock closed flat Tuesday after its sales missed third-quarter sales forecasts and on mixed results for its messenger RNA-based flu shot.

Investors Business Daily

Dow Jones Falls 125 Points After Key Housing Data; Caterpillar Dives On Earnings

The Dow Jones Industrial Average dropped 125 points Tuesday after key housing data. Tesla stock continued to slide after Monday's dive.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.